Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Serine Supplementation for Obese Subjects With Fatty Liver Disease [Phase 1, Phase 2]
The clinical trial evaluating serine supplementation for obese individuals with non-alcoholic fatty liver disease has completed Phase 1 and …
-
CLINICAL_TRIALS trial_result · 2016-09-29Clinical Trial Update: Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) Patients [Phase 2]
A Phase 2 safety pilot study of a Farnesoid X Receptor (FXR) agonist in non-alcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: C1q/TNF-related Proteins in Non-Alcoholic Fatty Liver Disease
A clinical trial investigates C1q/TNF-related proteins in non-alcoholic fatty liver disease. Sponsor: Korea University; status is currently …
-
CLINICAL_TRIALS trial_result · 2016-09-14Clinical Trial Update: The Effects of Type of Exercise in Non-alcoholic Fatty Liver Disease [NA]
A completed Mahidol University clinical trial examines the effects of different types of exercise on non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2016-08-18Clinical Trial Update: Relationship of Metabolic Abnormalities to Hepatic Steatosis in HIV
A completed clinical trial evaluating the relationship between metabolic abnormalities and hepatic steatosis in people with HIV.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-08-09Clinical Trial Update: Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease
This clinical trial update reports on a completed study evaluating infrared spectroscopy as a diagnostic method to assess the severity of no…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver Disease [NA]
This is a completed clinical trial evaluating phlebotomy as a treatment for non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH) [Phase 2]
A Phase 2 clinical trial evaluating the effect of fish oil on non-alcoholic steatohepatitis has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: The Effect of Probiotics on Non Alcoholic Fatty Liver Disease [Phase 1]
The Rabin Medical Center-sponsored Phase 1 trial investigating probiotics for non-alcoholic fatty liver disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: EXIT: Prospective Study of the Response to Exercise
The EXIT trial, a prospective study evaluating the response to exercise, has completed in participants with fatty liver disease and type 2 d…
-
CLINICAL_TRIALS trial_result · 2016-03-30Clinical Trial Update: Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis [Phase 3]
This clinical trial update reports on the efficacy and safety of oltipraz for reducing liver fat in adults with non-alcoholic fatty liver di…
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008) [Phase 1]
Phase 1 trial assessing changes in hepatic fat after administration of MK-4074 with pioglitazone; completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver Disease [Phase 1]
Phase 1 trial evaluating altered drug disposition and diagnostic biomarkers for chronic inflammatory liver disease in individuals with fatty…
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: Optimizing the Beneficial Health Effects of Exercise for Diabetes: Focus on the Liver! [NA]
This entry notes the completion of a clinical trial investigating how exercise affects health outcomes in type 2 diabetes with a focus on li…
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients [Phase 2]
This clinical trial update reports the completion and posting of results from a Phase 2 study evaluating LCQ908 for non-alcoholic fatty live…
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease [Phase 4]
Phase 4 trial comparing atorvastatin to vitamin E for non-alcoholic fatty liver disease; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLD [Phase 4]
This completed Phase 4 multicenter trial evaluated the safety and efficacy of lobeglitazone for decreasing intrahepatic fat contents in peop…
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Study of Fish Oil to Reduce ALT Levels in Adolescents [Phase 1]
Phase 1 trial assessing whether fish oil can lower ALT levels in adolescents with fatty liver diseases; the study has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: DHA and Vitamin D in Children With Biopsy-proven NAFLD [Phase 3]
A Phase 3 clinical trial evaluating DHA and vitamin D in children with biopsy-confirmed non-alcoholic fatty liver disease (NAFLD) and non-al…
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: "Hepafast" in Non-alcoholic Fatty Liver Disease (NAFLD) [NA]
A clinical trial evaluating Hepafast for non-alcoholic fatty liver disease (NAFLD) with obesity has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: Silymarin for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) [Phase 2]
A Phase 2 clinical trial evaluating silymarin for non-alcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Effect of Diet Composition on Liver Fat and Glucose Metabolism [NA]
A completed clinical trial investigated how diet composition affects liver fat and glucose metabolism in fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study. [NA]
A pilot clinical trial investigates how fructose intake affects intestinal permeability in people with non-alcoholic fatty liver disease and…
-
CLINICAL_TRIALS trial_result · 2015-08-28Clinical Trial Update: Effect of Ginger Supplement on Non-alcoholic Fatty Liver [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating a ginger supplement for non-alcoholic fatty liver disease has completed. The study was sponsored by Dr…
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease Patients [Phase 2]
Phase 2 trial results update showing safety and efficacy data for HL Tablet in patients with non-alcoholic fatty liver disease.